drugset / Trial / NCT00197106
Treatment Of Symptomatic Asthma In Children
RandomizedParallel-groupDouble-blindTreatment
Summary
This study is being conducted to investigate whether in childhood salmeterol/ fluticasone propionate 50/100 bd delivered via the Diskus® inhaler and fluticasone propionate 200 mcg bd delivered via the Diskus® inhaler are non- inferior in terms of symptom control. Additionally we aim to show that salmeterol/ fluticasone propionate 50/100 bd is at least as good in terms of lung function improvement and bronchial hyperreactivity and enables a steroid-sparing management of asthma in children.
Timeline
- Start
- 2005-06
- Primary completion
- 2008-10
- Completion
- 2008-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Fluticasone propionate | Other / unclassified | 100 ug | Inhaled |
| Subject | Fluticasone propionate | Other / unclassified | 200 ug | Inhaled |
| Comparator | Salmeterol | Other / unclassified | 50 ug | Inhaled |